DDS-specialized, respected global healthcare group with source technology

BIO & CHEMICAL R&D

Source Technology Pipeline

  • HOME
  • R&D
  • Source Technology Pipeline
LASTINA
Microsphere
sustained release of micro-particle
Characteristic
Spherical Drug Delivery System in Micro Units that Slowly Release Drugs
  • Maintains sustained medicinal effect via 1 injection a day/2 weeks/3-6 months
  • Mass production possible via aseptic manufacturing process
BC World Pipeline
BCWP-D001 : Anticancer drugs
BCWP-D004 : Anticancer drugs
BCWP-D006 : Anticancer drugs
BCWP-D009 : antipsychotics
BCWP-S002 : fillers
SCF-Liposome
Target organ targeting
Characteristic
Technology to increase the bioavailability of existing drugs through liposome technology
  • Increase solubilization for poorly soluble drugs and reduce side effects by reducing drug toxicity
  • Excellent drug reproducibility and mass production
BC World Pipeline
BCWP-Y001 : Anticancer drugs
BCWP-Y002 : antifungal agents
DLSF GRS
oral gastro retentive float system
Characteristic
Upstream drug delivery system
  • Adjustable drug release
  • Minimize adverse effects due to drug absorption and drug interactions
BC World Pipeline
BCWP-A001 : multiple antibiotics
BCWP-C003 : hyperlipidemia diabetes mellitus
BCWP-C003 : multiple antibiotics
MPIT FDT-SR
slow-moving & fast-breaking
Characteristic
  • It disintegrates within a few seconds in oral cavity and can be taken without water
  • Improved patient comfort
  • Strengthen the effect persistence of drugs
BC World Pipeline
BCWP-E001 : antiepileptic
BCWP-E003 : ADHD therapeutic agents
BCWP-E004 : benign prostatic hyperplasia
top